Content about chemotherapy

January 15, 2014

Drug maker AbbVie has started a late-stage clinical trial of an experimental drug for treating triple-negative breast cancer, the company said Wednesday.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

November 4, 2013

The Food and Drug Administration has asked Ariad Pharmaceuticals to suspend marketing and sales of a chemotherapy drug for leukemia due to the risk of life-threatening side effects, the agency said.

November 1, 2013

The Food and Drug Administration has approved a new drug for leukemia made by Genentech, the agency said Friday.

October 22, 2013

Biotech drug maker Amgen has acquired from Roche the rights to drugs used to boost the immune systems of cancer patients on chemotherapy in 100 markets.

September 16, 2013

The Food and Drug Administration has approved a generic chemotherapy pill for treating colorectal and breast cancers, the agency said Monday.

September 12, 2013

While pertussis is often considered a childhood disease, a new study from GlaxoSmithKline indicates it's a lot more common among older adults than commonly reported.

August 27, 2013

Psi Bands on Tuesday announced the addition of a sixth design to its line of acupressure wristbands — a new blue and black plaid unisex design called “Fast Track.”

July 31, 2013

The Natural Dentist, a line of therapeutic oral care products, and Dr. Susan Calderbank, a leading dentist in oral health for patients undergoing chemotherapy and head and neck radiation, announced a partnership to raise awareness about the oral complications of cancer treatments in a joint effort to help patients manage these often debilitating side effects.

June 10, 2013

Drug maker Amag Pharmaceuticals has licensed the U.S. commercial rights to a treatment for a common side effect of cancer treatments from another company, Amag said Monday.

April 2, 2013

The Natural Dentist has launched “Rinse for Relief,” an online resource for proper oral care aimed at cancer patients suffering from mouth sores and other oral ailments, the fourth most common side effect of chemotherapy treatments.

March 28, 2013

In February 2006, Christopher and Kelly Jerry endured every parent’s worst nightmare when, during what was supposed to be her last course of chemotherapy treatment at Cleveland’s Rainbow Babies and Children’s Hospital, their 2-year-old daughter, Emily, unexpectedly died.

January 25, 2013

The Food and Drug Administration has approved a new use for a cancer drug made by Roche unit Genentech, the agency said.

December 28, 2012

Teva Pharmaceuticals has received approval of their new drug application for topotecan hydrochloride injection, a treatment for small cell lung cancer, according to Food and Drug Administration records.

December 10, 2012

The Food and Drug Administration has approved a new use for a cancer drug made by Johnson & Johnson, the agency said Monday.

October 26, 2012

A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.

October 22, 2012

A deal that would make a specialty pharmacy a distribution source for a new liquid chemotherapy drug may benefit breast cancer patients who have trouble swallowing pills.

September 28, 2012

Drug maker OncoGenex Pharmaceuticals has started its third late-stage clinical trial of a drug for treating a type of lung cancer.

September 18, 2012

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


September 11, 2012

Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

August 30, 2012

The Food and Drug Administration has approved a biosimilar drug made by Teva Pharmaceutical Industries for a condition that results from certain chemotherapy treatments, the drug maker said Thursday.

August 15, 2012

A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.

August 9, 2012

Hospira has relaunched a generic chemotherapy drug for the U.S. market, the generic drug maker said Thursday.

August 9, 2012

Drug maker Sagent Pharmaceuticals has launched a generic chemotherapy drug, the company said Thursday.

© 2014 Drug Store News. All Rights Reserved.